Literature DB >> 26131313

Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells.

Shira Yanovsky-Dagan1, Hagar Mor-Shaked1, Rachel Eiges1.   

Abstract

Pathogenic mutations involving DNA repeat expansions are responsible for over 20 different neuronal and neuromuscular diseases. All result from expanded tracts of repetitive DNA sequences (mostly microsatellites) that become unstable beyond a critical length when transmitted across generations. Nearly all are inherited as autosomal dominant conditions and are typically associated with anticipation. Pathologic unstable repeat expansions can be classified according to their length, repeat sequence, gene location and underlying pathologic mechanisms. This review summarizes the current contribution of mutant pluripotent stem cells (diseased human embryonic stem cells and patient-derived induced pluripotent stem cells) to the research of unstable repeat pathologies by focusing on particularly large unstable noncoding expansions. Among this class of disorders are Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome, myotonic dystrophy type 1 and myotonic dystrophy type 2, Friedreich ataxia and C9 related amyotrophic lateral sclerosis and/or frontotemporal dementia, Facioscapulohumeral Muscular Dystrophy and potentially more. Common features that are typical to this subclass of conditions are RNA toxic gain-of-function, epigenetic loss-of-function, toxic repeat-associated non-ATG translation and somatic instability. For each mechanism we summarize the currently available stem cell based models, highlight how they contributed to better understanding of the related mechanism, and discuss how they may be utilized in future investigations.

Entities:  

Keywords:  Disease modeling; Epigenetics; Human embryonic stem cells; Patient-derived induced pluripotent stem cells; RNA toxicity; Repeat somatic instability; Unstable repeat associated disorders; repeat-associated non-ATG translation

Year:  2015        PMID: 26131313      PMCID: PMC4478629          DOI: 10.4252/wjsc.v7.i5.823

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  164 in total

1.  Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.

Authors:  Clotilde Lagier-Tourenne; Michael Baughn; Frank Rigo; Shuying Sun; Patrick Liu; Hai-Ri Li; Jie Jiang; Andrew T Watt; Seung Chun; Melanie Katz; Jinsong Qiu; Ying Sun; Shuo-Chien Ling; Qiang Zhu; Magdalini Polymenidou; Kevin Drenner; Jonathan W Artates; Melissa McAlonis-Downes; Sebastian Markmiller; Kasey R Hutt; Donald P Pizzo; Janet Cady; Matthew B Harms; Robert H Baloh; Scott R Vandenberg; Gene W Yeo; Xiang-Dong Fu; C Frank Bennett; Don W Cleveland; John Ravits
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

2.  Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions.

Authors:  Christopher E Pearson; Mandy Tam; Yuh-Hwa Wang; S Erin Montgomery; Arvin C Dar; John D Cleary; Kerrie Nichol
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

3.  Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.

Authors:  Dobrila D Rudnicki; Susan E Holmes; Mark W Lin; Charles A Thornton; Christopher A Ross; Russell L Margolis
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

4.  Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Jihae Shin; Yuan Yuan; Stuart G Beattie; Thurman M Wheeler; Charles A Thornton; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

5.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Authors:  Zihui Xu; Mickael Poidevin; Xuekun Li; Yujing Li; Liqi Shu; David L Nelson; He Li; Chadwick M Hales; Marla Gearing; Thomas S Wingo; Peng Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

6.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

7.  The Friedreich ataxia GAA triplet repeat: premutation and normal alleles.

Authors:  L Montermini; E Andermann; M Labuda; A Richter; M Pandolfo; F Cavalcanti; L Pianese; L Iodice; G Farina; A Monticelli; M Turano; A Filla; G De Michele; S Cocozza
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

8.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

Review 9.  Repeat-associated non-ATG (RAN) translation in neurological disease.

Authors:  John D Cleary; Laura P W Ranum
Journal:  Hum Mol Genet       Date:  2013-08-04       Impact factor: 6.150

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  7 in total

Review 1.  From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.

Authors:  Aziza Rashed Alrafiah
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

2.  Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.

Authors:  Fernando Morales; Eyleen Corrales; Baili Zhang; Melissa Vásquez; Carolina Santamaría-Ulloa; Hazel Quesada; Mario Sirito; Marcos R Estecio; Darren G Monckton; Ralf Krahe
Journal:  Hum Mol Genet       Date:  2021-12-27       Impact factor: 5.121

3.  C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.

Authors:  Rustam Esanov; Kinsley C Belle; Marka van Blitterswijk; Veronique V Belzil; Rosa Rademakers; Dennis W Dickson; Leonard Petrucelli; Kevin B Boylan; Derek M Dykxhoorn; Joanne Wuu; Michael Benatar; Claes Wahlestedt; Zane Zeier
Journal:  Exp Neurol       Date:  2015-12-31       Impact factor: 5.330

Review 4.  Human induced pluripotent stem cells for monogenic disease modelling and therapy.

Authors:  Paola Spitalieri; Valentina Rosa Talarico; Michela Murdocca; Giuseppe Novelli; Federica Sangiuolo
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

Review 5.  Cells of Matter-In Vitro Models for Myotonic Dystrophy.

Authors:  Magdalena Matloka; Arnaud F Klein; Frédérique Rau; Denis Furling
Journal:  Front Neurol       Date:  2018-05-23       Impact factor: 4.003

6.  Genome-wide screening for genes involved in the epigenetic basis of fragile X syndrome.

Authors:  Dan Vershkov; Atilgan Yilmaz; Ofra Yanuka; Anders Lade Nielsen; Nissim Benvenisty
Journal:  Stem Cell Reports       Date:  2022-04-14       Impact factor: 7.294

7.  Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2.

Authors:  Paola Spitalieri; Rosa V Talarico; Michela Murdocca; Luana Fontana; Marzia Marcaurelio; Elena Campione; Roberto Massa; Giovanni Meola; Annalucia Serafino; Giuseppe Novelli; Federica Sangiuolo; Annalisa Botta
Journal:  Front Physiol       Date:  2018-07-27       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.